Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dyne Therapeutics Inc DYN

Healthcare Biotechnology
Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is... see more

Recent & Breaking News (NDAQ:DYN)

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm!

PR Newswire September 15, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

Accesswire September 15, 2024

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Violating Securities Laws And The Firm Invites Investor Participation

Accesswire September 15, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Stockholders to Inquire about Securities Investigation

Accesswire September 15, 2024

An Investigation Has Been Launched Into Dyne Therapeutics Inc For Fraudulent Practices And Shareholders Can Assist The Schall Law Firm

Accesswire September 14, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

Accesswire September 13, 2024

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Possible Securities Law Violations And Impacted Investors Should Participate

Accesswire September 13, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dyne Therapeutics, Inc. (DYN) and Encourages Investors to Learn More About the Investigation

Accesswire September 13, 2024

Dyne Therapeutics Inc May Have Committed Securities Fraud And The Schall Law Firm Invites Stakeholders To Join An Inquiry

Accesswire September 12, 2024

Dyne Therapeutics, Inc.(DYN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Accesswire September 12, 2024

Dyne Therapeutics, Inc. (DYN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire September 11, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

Accesswire September 11, 2024

Dyne Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - DYN

Accesswire September 11, 2024

The Schall Law Firm Is Looking Into Dyne Therapeutics, Inc. For Possible Securities Law Violations And Impacted Investors Are Urged To Reach Out

Accesswire September 11, 2024

Dyne Therapeutics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - DYN

Accesswire September 11, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dyne Therapeutics, Inc.(DYN) And Encourages Investors to Connect

Accesswire September 11, 2024

Levi & Korsinsky Reminds Dyne Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - DYN

Accesswire September 10, 2024

Dyne Therapeutics, Inc. (DYN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire September 10, 2024

Dyne Therapeutics Inc May Have Committed Securities Fraud And The Schall Law Firm Encourages Shareholders To Partake In An Inquiry

Accesswire September 10, 2024

Lost Money on Dyne Therapeutics, Inc.(DYN)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

Accesswire September 10, 2024